GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Gross Profit

Lifecome Biochemistry Co (SZSE:002868) Gross Profit : ¥-45.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co Gross Profit?

Lifecome Biochemistry Co's gross profit for the three months ended in Mar. 2024 was ¥13.1 Mil. Lifecome Biochemistry Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-45.1 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lifecome Biochemistry Co's gross profit for the three months ended in Mar. 2024 was ¥13.1 Mil. Lifecome Biochemistry Co's Revenue for the three months ended in Mar. 2024 was ¥160.4 Mil. Therefore, Lifecome Biochemistry Co's Gross Margin % for the quarter that ended in Mar. 2024 was 8.16%.

Lifecome Biochemistry Co had a gross margin of 8.16% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

During the past 12 years, the highest Gross Margin % of Lifecome Biochemistry Co was 40.44%. The lowest was -8.96%. And the median was 31.81%.


Lifecome Biochemistry Co Gross Profit Historical Data

The historical data trend for Lifecome Biochemistry Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co Gross Profit Chart

Lifecome Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.03 93.53 59.59 -9.25 -45.43

Lifecome Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.77 10.48 -24.66 -44.02 13.09

Competitive Comparison of Lifecome Biochemistry Co's Gross Profit

For the Biotechnology subindustry, Lifecome Biochemistry Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecome Biochemistry Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lifecome Biochemistry Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lifecome Biochemistry Co's Gross Profit falls into.



Lifecome Biochemistry Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lifecome Biochemistry Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=507.005 - 552.432
=-45.4

Lifecome Biochemistry Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=160.396 - 147.307
=13.1

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-45.1 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Lifecome Biochemistry Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=13.1 / 160.396
=8.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lifecome Biochemistry Co  (SZSE:002868) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lifecome Biochemistry Co had a gross margin of 8.16% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Lifecome Biochemistry Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Lifecome Biochemistry Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecome Biochemistry Co (SZSE:002868) Business Description

Traded in Other Exchanges
N/A
Address
No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Executives
Lou Li Jun Supervisors
Huang Hui Executives
Bao Zhong Shou Executives
Feng Zhen Wu Supervisors
Li Jun Hui Executives
Lai Tan Ping Directors, executives
Xu Chun Lin Director
Lai Jian Ping Directors, executives

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines